The Food and Drug Administration (FDA) said on Wednesday it is monitoring a potential safety issue involving Boston Scientific Corporation’s (NYSE:BSX) ENDOTAK RELIANCE defibrillation leads, following ...
The FDA has issued a safety alert for several models of Boston Scientific’s Endotak Reliance defibrillation leads after identifying a serious defect linked to 16 deaths and 386 injuries. The leads, ...
The FDA has updated its alert regarding Boston Scientific’s call for providers to check the connections of their patients’ implanted defibrillators, where calcification growth over time can prevent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results